Legal & General Group
LOXO

Legal & General Group’s Loxo Oncology, Inc LOXO Stock Holding History

Legal & General Group’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,764
Closed -$1.51M – 3374
2018
Q4 		$1.51M Buy
10,764
+634
+6% +$96.2K ﹤0.01% 1720
2018
Q3 		$1.73M Sell
10,130
-5
-0% -$840 ﹤0.01% 1757
2018
Q2 		$1.76M Buy
10,135
+1,549
+18% +$233K ﹤0.01% 1723
2018
Q1 		$991K Sell
8,586
-4,184
-33% -$445K ﹤0.01% 1889
2017
Q4 		$1.08M Sell
12,770
-272
-2% -$22.7K ﹤0.01% 1861
2017
Q3 		$1.2M Buy
13,042
+8,028
+160% +$624K ﹤0.01% 1790
2017
Q2 		$405K Buy
5,014
+1,332
+36% +$73.8K ﹤0.01% 2097
2017
Q1 		$154K Buy
3,682
+284
+8% +$11.7K ﹤0.01% 2355
2016
Q4 		$111K Buy
3,398
+2,052
+152% +$52.6K ﹤0.01% 2501
2016
Q3 		$34K Hold
1,346
– – ﹤0.01% 2696
2016
Q2 		$32K Buy
+1,346
New +$33.5K ﹤0.01% 2705

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Legal & General Group's LOXO Position: Q1 2019 in Review

Legal & General Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 10,764 shares — an estimated $1.51M sold.

Legal & General Group first reported a position in LOXO in Q2 2016 and held it in 11 quarters. The position peaked at $1.76M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Legal & General Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Legal & General Group sold 10,764 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.51M.
  • Legal & General Group first reported a position in Loxo Oncology, Inc in Q2 2016 and held it in 11 quarters.
  • Legal & General Group's Loxo Oncology, Inc position peaked at $1.76M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Legal & General Group's 13F filing for Q1 2019, filed 15 May 2019.